NF2 blocks Snail-mediated p53 suppression in mesothelioma

Area of Science:

• Oncology
• Molecular Biology
• Carcinogenesis

Background:

• Malignant pleural mesothelioma (MPM) is asbestos-induced, but its molecular mechanism remains unclear.
• Classical oncogenes and tumor suppressor genes show low mutation rates in MPM, suggesting a unique carcinogenic pathway.
• Understanding this pathway is crucial for developing targeted therapies.

Purpose of the Study:

• To elucidate the molecular mechanism of MPM carcinogenesis.
• To identify potential therapeutic targets for MPM.
• To investigate the role of RKIP, NF2, p53, and Snail in MPM development.

Main Methods:

• Silica treatment of mesothelioma and non-small cell lung cancer (NSCLC) cell lines to mimic MPM carcinogenesis.
• Analysis of protein expression and interactions, including Erk, Snail, p53, E-cadherin, and NF2.
• Evaluation of GN25, a p53-Snail interaction inhibitor, for its effects on p53 and apoptosis.

Main Results:

• Silica treatment reduced RKIP and E-cadherin, while increasing p-Erk and Snail.
• Snail inhibition restored p53 expression.
• NF2, frequently deleted in MPM, inhibited Snail-mediated p53 suppression and was stabilized by RKIP.
• GN25 induced p53 and apoptosis, indicating disruption of the p53-Snail interaction.

Conclusions:

• MPM carcinogenesis is linked to reduced RKIP/NF2, leading to Snail-mediated p53 suppression.
• The p53-Snail interaction is a key pathway in MPM development.
• GN25 represents a promising drug candidate for MPM treatment by targeting the p53-Snail interaction.